Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
Charles Turck, PharmD, BCPS, BCCCP
Hannah McManus, MD
Andrew Armstrong, MD, MSc
Navigating mCRPC Treatment: A Look at Abiraterone and Enzalutamide
How PSMA Scans Inform Metastatic Prostate Cancer Diagnosis and Treatment
Daniel Kwon, MD
Radium-223’s Potential Quality of Life Benefits for mCRPC Patients
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Betsy O'Donnell, MD
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
David Braun
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Munir Ghesani, MD
Enhancing HCC Outcomes Through Multidisciplinary Care
Hannah Lee, MD
Optimizing HCC Screening: Strategies to Overcome Common Barriers
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
David Braun, MD, PhD
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Robert Wong, MD
Key Highlights from SNMMI 2024
An Overview of the Fundamentals of PET-CT Imaging
An Exploration of Multiple Myeloma Treatments
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.